SEI Investments
CAPR icon

SEI Investments’s Capricor Therapeutics CAPR Stock Holding History

SEI Investments’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Sell
17,385
-420
-2% -$12.7K ﹤0.01% 2717
2026
Q1 		$541K Buy
17,805
+5,195
+41% +$138K ﹤0.01% 2625
2025
Q4 		$364K Buy
+12,610
New +$165K ﹤0.01% 2643
2017
Q3 		– Sell
-100
Closed -$1K – 3208
2017
Q2 		$1K Buy
+100
New +$1.83K ﹤0.01% 2915

Other funds holding CAPR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SEI Investments's CAPR Position: Q2 2026 in Review

SEI Investments reduced its Capricor Therapeutics (CAPR) stake by 2.4% in Q2 2026, selling an estimated $12.7K and leaving 17,385 shares worth $419K. The position accounts for ﹤0.01% of the portfolio, ranked #2717.

SEI Investments first reported a position in CAPR in Q2 2017 and has held it in 4 quarters since. The position peaked at $541K in Q1 2026. 170 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

  • SEI Investments held 17,385 shares of Capricor Therapeutics worth $419K as of Q2 2026.
  • SEI Investments sold 420 Capricor Therapeutics shares in Q2 2026, an estimated $12.7K.
  • Capricor Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2717 holding.
  • SEI Investments first reported a position in Capricor Therapeutics in Q2 2017 and has held it in 4 quarters since.
  • SEI Investments's Capricor Therapeutics position peaked at $541K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.